Stockreport

Belite Bio Announces Registered Direct Offering of $15 Million

Belite Bio, Inc - American Depositary Shares  (BLTE) 
PDF SAN DIEGO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc ("BLTE" or the "Company") (Nasdaq: BLTE), a clinical-stage biopharmaceutical drug development company focu [Read more]